ONVO רווח נקי למניה ב-12 החודשים האחרונים organovo.com

Organovo Holdings, Inc. (ONVO) management possesses strong scientific potential, yet has not yet converted research into profit. Net income per share dynamics confirm this thesis, with the value stabilizing at -10.42. A team of elite bioprinting engineers stabilizes the situation, while operational processes strictly comply with FDA medical standards for biomaterial disposal.
פילוחים אנליטיים ודוחות נתונים של חברת Organovo Corp (ONVO)

Earnings per share (EPS) serves as a key indicator of capital efficiency in fundamental analysis. The net income per share trend over the last four quarters visualizes the actual speed of profit generation. This metric is calculated by dividing the bottom-line financial result by the total number of outstanding securities. For Organovo Holdings, Inc. (ONVO), this figure reflects the high cost of R&D developments. Negative values confirm the absence of commercial revenue and the risk of depleting reserves during tissue bioprinting.